Mike Havrilla

Tracking Cancer Diagnostic and Therapeutic Stocks

The index is not meant to be a comprehensive list of cancer companies -- it is concentrated in the small/micro-cap space for speculative investors.


On Apr 13 10:10 AM experienced wrote:

> The list shows only a relative handful of cancer related r&d
> firms and gives a somewhat distorted picture. Many firms in the list
> are in financial trouble, making it unlikely that common shareholders
> will receive a return commensurate with risks. No timetables are
> given for approval, other than the test phase for certain compounds.
> There is not enough material here to make a well formed decision.

FDA, Clinical Trial Calendar Updates: SOMX, EPIX, HLUKY, ARKTF

Check out the Global Tobacco Index of 24 cos which is included with the other health indexes at BioMedReports.com:
biomedreports.com/heal...


On Apr 08 09:33 AM felixd wrote:

> I understand that Pharma is keenly focused on getting their products
> on the FDA docket for approval but it is not much use to an investor.
> The FDA approval process is just too slow, problematic, and almost
> always results in a delay. Indeed, FDA approvals of new drugs is
> a national embarrasment as fewer and fewer new drugs are being approvaed,
> despite the fact that pharma spends huge amounts in R&D.
>
> If you want an investible new development from the FDA it might well
> be in cigarettes. Now that FDA looks to take over full regulation
> of tobacco, and given the new added taxes on cigarettes, costs in
> US for a pack are now over $5 and will likely rise some more. In
> Mexico you can buy a pck for 20 pesos, or about a $1.80. Seems to
> me that the better investment is in a small tobacco barn located
> on the other side of the border in Mexico that is seeing business
> boom thanks to US taxes and the FDA.